Literature DB >> 11060087

Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis.

A Johansson1, A Ibrahim, I Göransson, U Eriksson, D Gurycova, J E Clarridge, A Sjöstedt.   

Abstract

Previous studies have demonstrated that the four subspecies of the human pathogen Francisella tularensis, despite showing marked variations in their virulence for mammals and originating from different regions in the Northern Hemisphere, display a very close phylogenetic relationship. This property has hampered the development of generally applicable typing methods. To overcome this problem, we evaluated the use of PCR for discrimination of the subspecies using various forms of long arbitrary primers or primers specific for repetitive extragenic palindromic sequences (REP) or enterobacterial repetitive intragenic consensus (ERIC) sequences. Patterns generated by use of REP, ERIC, or long arbitrary primers allowed differentiation at the species level and of the four subspecies of F. tularensis. With each of these three methods, similar or identical clustering of strains was found, and groups of strains of different geographical origins or differing in virulence showed distinct patterns. The discriminatory indices of the methods varied from 0.57 to 0.65; thus, the patterns were not sufficiently discriminatory to distinguish individual strains. The sequence of a fragment generated by amplification with an arbitrary primer was determined, and a region showing interstrain heterogeneity was identified. Specific primers were designed, and a PCR was developed that distinguished strains of F. tularensis subsp. holarctica from strains of other F. tularensis subspecies, including strains of the highly virulent F. tularensis subsp. tularensis. Notably, one European isolate showed the genetic pattern typical of the highly virulent F. tularensis subsp. tularensis, generally believed to exist only in North America. It is proposed that a combination of the specific PCR together with one method generating subspecies-specific patterns is suitable as a rapid and relatively simple strategy for discrimination of Francisella species and subspecies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060087      PMCID: PMC87560     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems.

Authors:  M. J. Struelens
Journal:  Clin Microbiol Infect       Date:  1996-08       Impact factor: 8.067

2.  Tularemia: a perusal of three hundred thirty-nine cases.

Authors:  F T DIENST
Journal:  J La State Med Soc       Date:  1963-04

3.  Specific detection of Coxiella burnetii through partial amplification of 23S rDNA.

Authors:  A Ibrahim; L Norlander; A Macellaro; A Sjöstedt
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

4.  Characterization of an endosymbiont infecting wood ticks, Dermacentor andersoni, as a member of the genus Francisella.

Authors:  M L Niebylski; M G Peacock; E R Fischer; S F Porcella; T G Schwan
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

5.  Amplification of anonymous DNA fragments using pairs of long primers generates reproducible DNA fingerprints that are sensitive to genetic variation.

Authors:  M Gillings; M Holley
Journal:  Electrophoresis       Date:  1997-08       Impact factor: 3.535

6.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 7.  DNA fingerprinting of medically important microorganisms by use of PCR.

Authors:  A van Belkum
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

8.  Comparison of different PCR approaches for typing of Francisella tularensis strains.

Authors:  V A de la Puente-Redondo; N G del Blanco; C B Gutiérrez-Martín; F J García-Peña; E F Rodríguez Ferri
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 9.  Tularemia: a 30-year experience with 88 cases.

Authors:  M E Evans; D W Gregory; W Schaffner; Z A McGee
Journal:  Medicine (Baltimore)       Date:  1985-07       Impact factor: 1.889

10.  The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis.

Authors:  A Sjöstedt; K Kuoppa; T Johansson; G Sandström
Journal:  Microb Pathog       Date:  1992-09       Impact factor: 3.738

View more
  36 in total

1.  Septic tularemia in 2 cottontop tamarins(Sanguinus oedipus).

Authors:  Amanda L Guthrie; Katherine L Gailbreath; Elizabeth A Cienava; Daniel S Bradway; Juan F Munoz Gutierrez
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

2.  Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.

Authors:  Stephen H Gregory; Wilbur H Chen; Stephanie Mott; John E Palardy; Nicholas A Parejo; Sara Heninger; Christine A Anderson; Andrew W Artenstein; Steven M Opal; Alan S Cross
Journal:  Vaccine       Date:  2010-02-17       Impact factor: 3.641

3.  Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm.

Authors:  Bernard La Scola; Khalid Elkarkouri; Wenjun Li; Tara Wahab; Ghislain Fournous; Jean-Marc Rolain; Silpak Biswas; Michel Drancourt; Catherine Robert; Stéphane Audic; Sven Löfdahl; Didier Raoult
Journal:  Genome Res       Date:  2008-04-11       Impact factor: 9.043

4.  Francisella tularensis bacteremia.

Authors:  X Haristoy; A Lozniewski; C Tram; D Simeon; L Bevanger; C Lion
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Ticks and bacterial tick-borne pathogens in Piemonte region, Northwest Italy.

Authors:  Dario Pistone; Massimo Pajoro; Eva Novakova; Nadia Vicari; Cesare Gaiardelli; Roberto Viganò; Camilla Luzzago; Matteo Montagna; Paolo Lanfranchi
Journal:  Exp Appl Acarol       Date:  2017-11-30       Impact factor: 2.132

6.  A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.

Authors:  Susan Twine; Mona Byström; Wangxue Chen; Mats Forsman; Igor Golovliov; Anders Johansson; John Kelly; Helena Lindgren; Kerstin Svensson; Carl Zingmark; Wayne Conlan; Anders Sjöstedt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis.

Authors:  Martien Broekhuijsen; Pär Larsson; Anders Johansson; Mona Byström; Ulla Eriksson; Eva Larsson; Richard G Prior; Anders Sjöstedt; Richard W Titball; Mats Forsman
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Problems in identification of Francisella philomiragia associated with fatal bacteremia in a patient with chronic granulomatous disease.

Authors:  A Friis-Møller; L E Lemming; N H Valerius; B Bruun
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Francisella tularensis subsp. novicida isolated from a human in Arizona.

Authors:  Dawn N Birdsell; Tasha Stewart; Amy J Vogler; Elisabeth Lawaczeck; Alisa Diggs; Tammy L Sylvester; Jordan L Buchhagen; Raymond K Auerbach; Paul Keim; David M Wagner
Journal:  BMC Res Notes       Date:  2009-11-06

10.  Whole genome single nucleotide polymorphism based phylogeny of Francisella tularensis and its application to the development of a strain typing assay.

Authors:  Gagan A Pandya; Michael H Holmes; Jeannine M Petersen; Sonal Pradhan; Svetlana A Karamycheva; Mark J Wolcott; Claudia Molins; Marcus Jones; Martin E Schriefer; Robert D Fleischmann; Scott N Peterson
Journal:  BMC Microbiol       Date:  2009-10-07       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.